Abstract

Thymic atrophy in sepsis is a critical disadvantage because it induces immunosuppression and increases the mortality rate as the disease progresses. However, the exact mechanism of thymic atrophy has not been fully elucidated. In this study, we discovered a novel role for VSIG4-positive peritoneal macrophages (V4(+) cells) as the principal cells that induce thymic atrophy and thymocyte apoptosis. In CLP-induced mice, V4(+) cells were activated after ingestion of invading microbes, and the majority of these cells migrated into the thymus. Furthermore, these cells underwent a phenotypic shift from V4(+) to V4(−) and from MHC II(low) to MHC II(+). In coculture with thymocytes, V4(+) cells mainly induced apoptosis in DP thymocytes via the secretion of TNF-α. However, there was little effect on CD4 or CD8 SP and DN thymocytes. V4(−) cells showed low levels of activity compared to V4(+) cells. Thymic atrophy in CLP-induced V4(KO) mice was much less severe than that in CLP-induced wild-type mice. In addition, V4(KO) peritoneal macrophages also showed similar activity to V4(−) cells. Taken together, the current study demonstrates that V4(+) cells play important roles in inducing immunosuppression via thymic atrophy in the context of severe infection. These data also suggest that controlling the function of V4(+) cells may play a crucial role in the development of new therapies to prevent thymocyte apoptosis in sepsis.

Details

Title
VSIG4(+) peritoneal macrophages induce apoptosis of double-positive thymocyte via the secretion of TNF-α in a CLP-induced sepsis model resulting in thymic atrophy
Author
Hae-Yun, Cho 1 ; Yang Yun Gyeong 1 ; Jeon Youkyoung 2 ; Chae-Kwan, Lee 3 ; Choi InHak 2 ; Soo-Woong, Lee 4 

 Innovative Therapeutics Research Institute, College of Medicine, Inje University, Busan, Republic of Korea (GRID:grid.411612.1) (ISNI:0000 0004 0470 5112) 
 Innovative Therapeutics Research Institute, College of Medicine, Inje University, Busan, Republic of Korea (GRID:grid.411612.1) (ISNI:0000 0004 0470 5112); Inje University College of Medicine, Department of Microbiology and Immunology, Busan, Republic of Korea (GRID:grid.411612.1) (ISNI:0000 0004 0470 5112) 
 College of Medical & Institute of Environmental and Occupational Medicine, Inje University, Department of Occupational and Environmental Medicine, Busan, Republic of Korea (GRID:grid.411612.1) (ISNI:0000 0004 0470 5112) 
 Innovative Therapeutics Research Institute, College of Medicine, Inje University, Busan, Republic of Korea (GRID:grid.411612.1) (ISNI:0000 0004 0470 5112); College of Medicine, Inje University, Department of Convergence Biomedical Science, Busan, Republic of Korea (GRID:grid.411612.1) (ISNI:0000 0004 0470 5112) 
Publication year
2021
Publication date
Jun 2021
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2530598056
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.